New research article in The Lancet Infectious Diseases> Efficacy and safety of #acoziborole in patients with human African #trypanosomiasis caused by #Trypanosoma brucei gambiense: a multicentre, open-label, single-arm, phase 2/3 trial https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(22)00660-0/fulltext #gambienseHAT #SleepingSickness
#sleepingsickness #gambiensehat #trypanosoma #trypanosomiasis #acoziborole